BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 20554483)

  • 1. Characterization of a unique IgG1 mAb CEX profile by limited Lys-C proteolysis/CEX separation coupled with mass spectrometry and structural analysis.
    Kim J; Jones L; Taylor L; Kannan G; Jackson F; Lau H; Latypov RF; Bailey B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(22):1973-81. PubMed ID: 20554483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of asparagine 330 deamidation in an Fc-fragment of IgG1 using cation exchange chromatography and peptide mapping.
    Zhang YT; Hu J; Pace AL; Wong R; Wang YJ; Kao YH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():65-71. PubMed ID: 24999246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cation exchange-HPLC and mass spectrometry reveal C-terminal amidation of an IgG1 heavy chain.
    Johnson KA; Paisley-Flango K; Tangarone BS; Porter TJ; Rouse JC
    Anal Biochem; 2007 Jan; 360(1):75-83. PubMed ID: 17113563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid identification of an antibody DNA construct rearrangement sequence variant by mass spectrometry.
    Scott RA; Rogers R; Balland A; Brady LJ
    MAbs; 2014; 6(6):1453-63. PubMed ID: 25484040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cysteinylation of a free cysteine in the Fab region of a recombinant monoclonal IgG1 antibody using Lys-C limited proteolysis coupled with LC/MS analysis.
    Gadgil HS; Bondarenko PV; Pipes GD; Dillon TM; Banks D; Abel J; Kleemann GR; Treuheit MJ
    Anal Biochem; 2006 Aug; 355(2):165-74. PubMed ID: 16828048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.
    Huang L; Lu J; Wroblewski VJ; Beals JM; Riggin RM
    Anal Chem; 2005 Mar; 77(5):1432-9. PubMed ID: 15732928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and identification of a serine to arginine sequence variant in a therapeutic monoclonal antibody.
    Ren D; Zhang J; Pritchett R; Liu H; Kyauk J; Luo J; Amanullah A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2877-84. PubMed ID: 21900054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct identification and quantification of aspartyl succinimide in an IgG2 mAb by RapiGest assisted digestion.
    Huang HZ; Nichols A; Liu D
    Anal Chem; 2009 Feb; 81(4):1686-92. PubMed ID: 19146457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells.
    Beck A; Bussat MC; Zorn N; Robillard V; Klinguer-Hamour C; Chenu S; Goetsch L; Corvaïa N; Van Dorsselaer A; Haeuw JF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):203-18. PubMed ID: 15833284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of degradants in acidic peak of cation exchange chromatography in an IgG1 monoclonal antibody formed on long-term storage in a liquid formulation.
    Gandhi S; Ren D; Xiao G; Bondarenko P; Sloey C; Ricci MS; Krishnan S
    Pharm Res; 2012 Jan; 29(1):209-24. PubMed ID: 21845507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of anomalous charge variant profile reveals discrete pH-dependent conformations and conformation-dependent charge states within the CDR3 loop of a therapeutic mAb.
    Lan W; Valente JJ; Ilott A; Chennamsetty N; Liu Z; Rizzo JM; Yamniuk AP; Qiu D; Shackman HM; Bolgar MS
    MAbs; 2020; 12(1):1763138. PubMed ID: 32432964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-dimensional fluorescence difference gel electrophoresis for comparison of affinity and non-affinity based downstream processing of recombinant monoclonal antibody.
    Grzeskowiak JK; Tscheliessnig A; Toh PC; Chusainow J; Lee YY; Wong N; Jungbauer A
    J Chromatogr A; 2009 Jun; 1216(24):4902-12. PubMed ID: 19423113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of degradation processes in IgG1 monoclonal antibodies by limited proteolysis coupled with weak cation-exchange HPLC.
    Lau H; Pace D; Yan B; McGrath T; Smallwood S; Patel K; Park J; Park SS; Latypov RF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(11-12):868-76. PubMed ID: 20206584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of therapeutic antibody charge variants using cation exchange displacement chromatography.
    Zhang T; Bourret J; Cano T
    J Chromatogr A; 2011 Aug; 1218(31):5079-86. PubMed ID: 21700290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study in glycation of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior.
    Quan C; Alcala E; Petkovska I; Matthews D; Canova-Davis E; Taticek R; Ma S
    Anal Biochem; 2008 Feb; 373(2):179-91. PubMed ID: 18158144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of IgG1 immunoglobulins and peptide-Fc fusion proteins by limited proteolysis in conjunction with LC-MS.
    Kleemann GR; Beierle J; Nichols AC; Dillon TM; Pipes GD; Bondarenko PV
    Anal Chem; 2008 Mar; 80(6):2001-9. PubMed ID: 18293943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-fucosylation of an antibody light chain: characterization of a modification occurring on an IgG1 molecule.
    Valliere-Douglass JF; Brady LJ; Farnsworth C; Pace D; Balland A; Wallace A; Wang W; Treuheit MJ; Yan B
    Glycobiology; 2009 Feb; 19(2):144-52. PubMed ID: 18952827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of intact antibodies by high-resolution LTQ Orbitrap mass spectrometry.
    Zhang J; Liu H; Katta V
    J Mass Spectrom; 2010 Jan; 45(1):112-20. PubMed ID: 19943324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody.
    Zhang T; Zhang J; Hewitt D; Tran B; Gao X; Qiu ZJ; Tejada M; Gazzano-Santoro H; Kao YH
    Anal Chem; 2012 Aug; 84(16):7112-23. PubMed ID: 22794164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability.
    Dillon TM; Bondarenko PV; Rehder DS; Pipes GD; Kleemann GR; Ricci MS
    J Chromatogr A; 2006 Jul; 1120(1-2):112-20. PubMed ID: 16448656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.